OPTOSURGICAL LLC — Department of Health and Human Services SBIR Phase II: AH04
OPTOSURGICAL LLC — SBIR Phase II award from Department of Health and Human Services.
Phase II SBIR prototype / development signal
- Phase II is where Department of Health and Human Services funds deeper R&D after feasibility. Incumbents with Phase II history are serious competitors on adjacent topics.
- Use this award as past-performance context and to map customer organizations for STRATFI/TACFI-style transition planning.
- At $3,500,000, this is a large obligation for typical SBIR Phase sizing — worth reviewing for scope breadth and teaming opportunity.
- Topic code AH04 links this award to a solicitation family — search the same topic stem for incumbents and recompete timing.
- Amount
- $3,500,000
- Agency
- Department of Health and Human Services · National Institutes of Health
- Program / Phase
- SBIR · Phase II
- Topic
- AH04
- Solicitation
- 75N91023R00041
- NAICS
- —
- Place of performance
- DE
- Period
- —
Description
The project aims to advance the development of BL-760, a near-infrared contrast agent designed for clear intraoperative identification of bile ducts. This novel dye addresses the significant medical issue of bile duct injury during hepatobiliary surgeries (e.g., cholecystectomy, hepatectomy), impacting over 1 million patients annually. The project plans to produce BL-760 with high quality standards (GMP) and to conduct rigorous safety tests in a controlled lab environment (GLP), at the allow for Investigational New Drug (IND)-enabling studies to test the dye in humans. The project outcome will improve patient outcomes and set a new standard of care in the field of hepatobiliary surgery.